BSECoral Laboratories LtdMediumNeutral
Announced Thu, 2 Apr · 12:31 IST

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, the Board of Directors of the Company in its meeting ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹383.00
prior close
₹391.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.0+0.0+0.8+4.2+3.1+5.2+5.7+6.5+11.1+7.6+10.4+32.8+56.7
Up moveDown movePending
AI summary

Coral Laboratories' Board meeting on April 2, 2026 approved the re-appointment of Mr. Malay Doshi as an Independent Director for a second term of 5 years (May 27, 2026 to May 26, 2031). The re-appointment is subject to shareholder approval via postal ballot and e-voting. Mr. Malay Doshi is a Chartered Accountant and LLB holder who owns Malay Doshi & Associates, a professional services firm. He is not related to any directors, KMP, or promoters of the company. The company has appointed M/s SARK & Associates as scrutinizer for the voting process.

Likely market impact

This is a routine corporate governance matter with no material impact on the stock. Shareholder approval through postal ballot is a standard procedure for independent director re-appointments beyond the first term.